glp-1 and neuroinflammation A schematic representation of the mechanism of glucagon-like peptide-1 Frontiers | The immunomodulatory effects

A new clinical study from the Mayo Clinic, published in Anesthesia & Analgesia (2026) , provides critical insights into how these medications influence gastric physiology and potentially increase the risk of pulmonary aspiration during anesthesia

These changes will affect fully insured large group commercial members, with a significant shift coming on January 1, 2025, when coverage for these medications will be discontinued altogether

Like semaglutide, it is aweekly injection[4]

You dont really need a doctor to tell you that eating fruits and vegetables is a good thing, right

Each one has practical differences worth knowing, and technique matters a lot more than which site you pick